Irina A. Gololobova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Irina A. Gololobova has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
A.V. Siprov
2 shared publicationsE.V. Romanova
2 shared publications- Aleksandr V. Siprov
National Research Ogarev Mordovia State University, Saransk, RUSSIA
1 shared publication - Alexandra Sain
Vladimir Zelman Center for Neurobiology and Brain Rehabilitation, Skolkovo Institute of Science and Technology, 30 Bolshoy Boulevard, 121205 Moscow, Russia
1 shared publication D.K. Khamidov
1 shared publicationD.Y. Shubin
1 shared publication
Latest Publications
- Open Access
- 9 January 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (1) , 85
Minimally Invasive Endovascular Administration for Targeted PLGA Nanoparticles Delivery to Brain, Salivary Glands, Kidney and Lower Limbs
Background: While intravenous administration of nanoparticles (NPs) is effective for targeting the lungs and liver, directing them to other organs and tissues remains challenging. Methods: Here, we report alternative administration routes that improve organ-specific accumulation of poly (lactic-co-glycolic acid) (PLGA) NPs (100 nm, negatively charged) loaded with the near-infrared dye Cyanine 7 (Cy7). NP cytotoxicity was evaluated in HEK293, mMSCs, C2C12, L929, and RAW264.7 cells. Hemocompatibility was assessed using WBCs and RBCs. NPs were administered via the tail vein, carotid, renal, and femoral arteries in BALB/c mice. Administration safety was evaluated by laser speckle contrast imaging and histological analysis. NP biodistribution and accumulation were assessed using in vivo and ex vivo fluorescence tomography and confocal microscopy of cryosections. Results: PLGA-Cy7 NPs demonstrate low cytotoxicity even at high doses and exhibit good hemocompatibility. Administration of NPs through the mouse carotid, renal, and femoral arteries significantly increases accumulation in the target ipsilateral brain hemisphere (31.7-fold) and salivary glands (28.3-fold), kidney (13.7-fold), and hind paw (3.6-fold), respectively, compared to intravenous administration. Injection of NPs through arteries supplying the target organs and tissues does not result in significant changes in blood flow, morphological alterations, or irreversible embolization of vessels, provided the procedure is performed correctly and the optimal dosage is used. Conclusions: These results highlight the potential of intra-arterial delivery of NPs for organ-specific drug targeting, underscoring the synergistic impact of advances in materials science, minimally invasive endovascular surgery, and nanomedicine.
- 9 January 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (1) , 85
Open AccessMinimally Invasive Endovascular Administration for Targeted PLGA Nanoparticles Delivery to Brain, Salivary Glands, Kidney and Lower Limbs
Background: While intravenous administration of nanoparticles (NPs) is effective for targeting the lungs and liver, directing them to other organs and tissues remains challenging. Methods: Here, we report alternative administration routes that improve organ-specific accumulation of poly (lactic-co-glycolic acid) (PLGA) NPs (100 nm, negatively charged) loaded with the near-infrared dye Cyanine 7 (Cy7). NP cytotoxicity was evaluated in HEK293, mMSCs, C2C12, L929, and RAW264.7 cells. Hemocompatibility was assessed using WBCs and RBCs. NPs were administered via the tail vein, carotid, renal, and femoral arteries in BALB/c mice. Administration safety was evaluated by laser speckle contrast imaging and histological analysis. NP biodistribution and accumulation were assessed using in vivo and ex vivo fluorescence tomography and confocal microscopy of cryosections. Results: PLGA-Cy7 NPs demonstrate low cytotoxicity even at high doses and exhibit good hemocompatibility. Administration of NPs through the mouse carotid, renal, and femoral arteries significantly increases accumulation in the target ipsilateral brain hemisphere (31.7-fold) and salivary glands (28.3-fold), kidney (13.7-fold), and hind paw (3.6-fold), respectively, compared to intravenous administration. Injection of NPs through arteries supplying the target organs and tissues does not result in significant changes in blood flow, morphological alterations, or irreversible embolization of vessels, provided the procedure is performed correctly and the optimal dosage is used. Conclusions: These results highlight the potential of intra-arterial delivery of NPs for organ-specific drug targeting, underscoring the synergistic impact of advances in materials science, minimally invasive endovascular surgery, and nanomedicine.
- Open Access
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №4 2025,p. 13
PROSPECTS FOR THE USE OF EMPAGLIFLOZIN IN COMORBID PATHOLOGY: THE RESULTS OF CLINICAL TRIALS
- 1 January 2025
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №4 2025,p. 13
Open AccessPROSPECTS FOR THE USE OF EMPAGLIFLOZIN IN COMORBID PATHOLOGY: THE RESULTS OF CLINICAL TRIALS
- Open Access
- 1 January 2023
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №5 2023,p. 83
MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF LESCH-NYHAN SYNDROME
- 1 January 2023
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №5 2023,p. 83
Open AccessMODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF LESCH-NYHAN SYNDROME
- Open Access
- 1 January 2023
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №4 2023,p. 31
INFLUENCE OF THE COMBINED USE OF LIPOSOMAL FORMS OF CYTOSTATICS AND ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON INDICATORS OF SPERMATOGENESIS IN RATS WITH EXPERIMENTAL NEOPLASY
- 1 January 2023
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in Современные проблемы науки и образования (Modern Problems of Science and Education)
- No. №4 2023,p. 31
Open AccessINFLUENCE OF THE COMBINED USE OF LIPOSOMAL FORMS OF CYTOSTATICS AND ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON INDICATORS OF SPERMATOGENESIS IN RATS WITH EXPERIMENTAL NEOPLASY